Literature DB >> 3272143

The design, synthesis and antileukemic activity of 5-alkynyl-1-beta-D-ribofuranosylimidazole-4-carboxamides.

A Matsuda, N Minakawa, T Sasaki, T Ueda.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3272143     DOI： 10.1248/cpb.36.2730

Source DB:  PubMed          Journal:  Chem Pharm Bull (Tokyo)        ISSN： 0009-2363            Impact factor:   1.645


× No keyword cloud information.
  5 in total

Review 1.  IMP dehydrogenase: structure, mechanism, and inhibition.

Authors:  Lizbeth Hedstrom
Journal:  Chem Rev       Date:  2009-07       Impact factor: 60.622

2.  Antiviral activities of 5-ethynyl-1-beta-D-ribofuranosylimidazole-4- carboxamide and related compounds.

Authors:  E De Clercq; M Cools; J Balzarini; R Snoeck; G Andrei; M Hosoya; S Shigeta; T Ueda; N Minakawa; A Matsuda
Journal:  Antimicrob Agents Chemother       Date:  1991-04       Impact factor: 5.191

3.  Antiviral activities of ribavirin, 5-ethynyl-1-beta-D-ribofuranosylimidazole-4-carboxamide, and 6'-(R)-6'-C-methylneplanocin A against several ortho- and paramyxoviruses.

Authors:  S Shigeta; S Mori; M Baba; M Ito; K Honzumi; K Nakamura; H Oshitani; Y Numazaki; A Matsuda; T Obara
Journal:  Antimicrob Agents Chemother       Date:  1992-02       Impact factor: 5.191

4.  Assay method for monitoring the inhibitory effects of antimetabolites on the activity of inosinate dehydrogenase in intact human CEM lymphocytes.

Authors:  J Balzarini; E De Clercq
Journal:  Biochem J       Date:  1992-11-01       Impact factor: 3.857

Review 5.  New Nucleoside Analogues for the Treatment of Hemorrhagic Fever Virus Infections.

Authors:  Erik De Clercq
Journal:  Chem Asian J       Date:  2019-08-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.